Immune cell adaptation from the gut barrier by CD14 monocyte activation, and Th2 cytokines pro-inflammatory releasing, analyzed from different duodenal tissue samples recovered from patients with liver cirrhosis or hepatic steatosis reported to controls, were presented in Figure 4, Figure 5 and Figure 6. This evidence concerns the gene CD14 and cirrhosis of liver.